The Dual Factor Model of Mental Health in Inpatients

Sponsor
Ruhr University of Bochum (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04450238
Collaborator
Stillachhaus Privatklinik (Other)
1,000
1
56.4
17.7

Study Details

Study Description

Brief Summary

The Dual Factor Model of mental health (DFM; Greensporn & Saklofske, 2001) postulates that mental health consists of two at least partially unrelated factors, the experience or absence of psycho-pathological symptoms (i.e. depressive symptoms) and the experience or absence of positive mental health (i.e. life satisfaction, meaningfulness). Both factors contribute to an individual's well-being and mental health.The DFM has been used as a framework to describe and evaluate participants' mental health in different settings in cross-sectional and longitudinal designs mostly outside of clinical settings. Psychological Interventions, such as cognitive-behavioral therapy are widely studied concerning their reduction of psycho-pathological symptoms. However, little is known about the effect of psychological interventions on the second factor (positive mental health) of the DFM. This is especially important, because the latter has been shown to contribute significantly to subjective well-being and to reduce the risk of suicidal intentions and behavior.

Primary, the authors aim to investigate the DFM in an inpatient sample over the course of time (pre-treatment, post-treatment, 6 and 12 months after discharge). Secondly, they aim to investigate the relationship between positive mental health and suicidal ideation over the course of time.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Routine care inpatient treatment

Detailed Description

Participants will be divided into four groups according to the DFM over the course of time:
  1. unhappy: high psychopathology and low positive mental health; depression and/or anxiety scores above published cut -offs and positive mental health scores under published cut offs.

  2. symptomatic but content: high psychopathology and high positive mental health; depression and/or anxiety scores above published cut -offs and normal to high positive mental health scores

  3. vulnerable: low psychopathology and low positive mental health; depression and/or anxiety scores under published cut -offs and positive mental health scores under published cut offs

  4. Complete mental health: low psychopathology and high positive mental health; depression and/or anxiety scores under published cut -offs normal to high positive mental health scores.

The authors will then depict the movements of patients through these groups graphically and use regression analyses to check for differences according to age, diagnosis and gender.

Towards the second aim they will use regression analyses to investigate the protective effect of positive mental health on suicidal ideation or behavior.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Dual Factor Model of Mental Health: A Longitudinal Study in Inpatients
Actual Study Start Date :
Jul 18, 2017
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Study Group

All participants are inpatients at the clinic "Stillachhaus" in Germany. They are receiving treatment for a variety of psychological disoders, mostly depressive disoders.

Behavioral: Routine care inpatient treatment
All participants are receiving inpatient treatment consisting of a variety of psychological interventions such as cognitive-behavioral therapy, third-wave interventions, psycho-education and in some cases medication.

Outcome Measures

Primary Outcome Measures

  1. Depression Anxiety Stress Scale-21 (DASS-21; Nilges et al., 2016) [In the first 3 days of treatment]

    Measures depression, anxiety and stress with 21 items. Scores range from 0-63 with higher scores indicating more severe anxiety, depression and stress.

  2. Depression Anxiety Stress Scale-21 (DASS-21; Nilges et al., 2016) [In the last three days of treatment]

    Measures depression, anxiety and stress with 21 items. Scores range from 0-63 with higher scores indicating more severe anxiety, depression and stress.

  3. Depression Anxiety Stress Scale-21 (DASS-21; Nilges et al., 2016) [6 months after discharge]

    Measures depression, anxiety and stress with 21 items. Scores range from 0-63 with higher scores indicating more severe anxiety, depression and stress.

  4. Depression Anxiety Stress Scale-21 (DASS-21; Nilges et al., 2016) [12 months after discharge]

    Measures depression, anxiety and stress with 21 items. Scores range from 0-63 with higher scores indicating more severe anxiety, depression and stress.

  5. Positive mental health scale (PMH; Lukat et al., 2016) [In the first 3 days of treatment]

    Measures positive psychological functioning with 9 items. Scores range from 0-27 with higher scores indicating more positive mental health.

  6. Positive mental health scale (PMH; Lukat et al., 2016) [In the last three days of treatment]

    Measures positive psychological functioning with 9 items. Scores range from 0-27 with higher scores indicating more positive mental health

  7. Positive mental health scale (PMH; Lukat et al., 2016) [6 months discharge]

    Measures positive psychological functioning with 9 items. Scores range from 0-27 with higher scores indicating more positive mental health

  8. Positive mental health scale (PMH; Lukat et al., 2016) [12 months discharge]

    Measures positive psychological functioning with 9 items. Scores range from 0-27 with higher scores indicating more positive mental health.

Secondary Outcome Measures

  1. Suicidal Behavior Questionnaire (SBQ; Osman et al., 2001) ). [In the first 3 days of treatment]

    Assesses past and current suicidal ideation and behavior. Scores range from 3-18 with higher scores indicating a higher risk for suicidal behavior.

  2. Suicidal Behavior Questionnaire (SBQ; Osman et al., 2001) ). [In the last three days of treatment]

    Assesses past and current suicidal ideation and behavior. Scores range from 3-18 with higher scores indicating a higher risk for suicidal behavior.

  3. Suicidal Behavior Questionnaire (SBQ; Osman et al., 2001) ). [6 months after discharge]

    Assesses past and current suicidal ideation and behavior. Scores range from 3-18 with higher scores indicating a higher risk for suicidal behavior.

  4. Suicidal Behavior Questionnaire (SBQ; Osman et al., 2001) ). [12 months after discharge]

    Assesses past and current suicidal ideation and behavior. Scores range from 3-18 with higher scores indicating a higher risk for suicidal behavior.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-inpatients at the Stiilachaus Privatklinik

Exclusion Criteria:

-None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stillachhaus Privatklinik Oberstdorf Bavaria Germany 87561

Sponsors and Collaborators

  • Ruhr University of Bochum
  • Stillachhaus Privatklinik

Investigators

  • Study Director: Juergen Margraf, Prof., Ruhr-University Bochum

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ruth von Brachel, Principal Investigator, Ruhr University of Bochum
ClinicalTrials.gov Identifier:
NCT04450238
Other Study ID Numbers:
  • 2017-387
First Posted:
Jun 29, 2020
Last Update Posted:
Nov 30, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ruth von Brachel, Principal Investigator, Ruhr University of Bochum
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2021